153 related articles for article (PubMed ID: 34273441)
21. It's difficult, but important, to make negative predictions.
Williams RV; Amberg A; Brigo A; Coquin L; Giddings A; Glowienke S; Greene N; Jolly R; Kemper R; O'Leary-Steele C; Parenty A; Spirkl HP; Stalford SA; Weiner SK; Wichard J
Regul Toxicol Pharmacol; 2016 Apr; 76():79-86. PubMed ID: 26785392
[TBL] [Abstract][Full Text] [Related]
22. A practical application of two in silico systems for identification of potentially mutagenic impurities.
Greene N; Dobo KL; Kenyon MO; Cheung J; Munzner J; Sobol Z; Sluggett G; Zelesky T; Sutter A; Wichard J
Regul Toxicol Pharmacol; 2015 Jul; 72(2):335-49. PubMed ID: 25980641
[TBL] [Abstract][Full Text] [Related]
23. Utility of published DNA reactivity alerts.
Myden A; Guesne SJ; Cayley A; Williams RV
Regul Toxicol Pharmacol; 2017 Aug; 88():77-86. PubMed ID: 28549899
[TBL] [Abstract][Full Text] [Related]
24. An assessment of mutagenicity of chemical substances by (quantitative) structure-activity relationship.
Honma M
Genes Environ; 2020; 42():23. PubMed ID: 32626544
[TBL] [Abstract][Full Text] [Related]
25. In silico prediction of chromosome damage: comparison of three (Q)SAR models.
Morita T; Shigeta Y; Kawamura T; Fujita Y; Honda H; Honma M
Mutagenesis; 2019 Mar; 34(1):91-100. PubMed ID: 30085209
[TBL] [Abstract][Full Text] [Related]
26. A practice of expert review by read-across using QSAR Toolbox.
Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
[TBL] [Abstract][Full Text] [Related]
27. A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.
Barber C; Antonucci V; Baumann JC; Brown R; Covey-Crump E; Elder D; Elliott E; Fennell JW; Gallou F; Ide ND; Jordine G; Kallemeyn JM; Lauwers D; Looker AR; Lovelle LE; McLaughlin M; Molzahn R; Ott M; Schils D; Oestrich RS; Stevenson N; Talavera P; Teasdale A; Urquhart MW; Varie DL; Welch D
Regul Toxicol Pharmacol; 2017 Nov; 90():22-28. PubMed ID: 28822875
[TBL] [Abstract][Full Text] [Related]
28. Quantitative weight of evidence method for combining predictions of quantitative structure-activity relationship models.
Tintó-Moliner A; Martin M
SAR QSAR Environ Res; 2020 Apr; 31(4):261-279. PubMed ID: 32065534
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing between expert and statistical systems for application under ICH M7.
Barber C; Hanser T; Judson P; Williams R
Regul Toxicol Pharmacol; 2017 Mar; 84():124-130. PubMed ID: 28057482
[No Abstract] [Full Text] [Related]
30. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?
Amberg A; Anger LT; Bercu J; Bower D; Cross KP; Custer L; Harvey JS; Hasselgren C; Honma M; Johnson C; Jolly R; Kenyon MO; Kruhlak NL; Leavitt P; Quigley DP; Miller S; Snodin D; Stavitskaya L; Teasdale A; Trejo-Martin A; White AT; Wichard J; Myatt GJ
Mutagenesis; 2019 Mar; 34(1):67-82. PubMed ID: 30189015
[TBL] [Abstract][Full Text] [Related]
31. Genetic toxicology in silico protocol.
Hasselgren C; Ahlberg E; Akahori Y; Amberg A; Anger LT; Atienzar F; Auerbach S; Beilke L; Bellion P; Benigni R; Bercu J; Booth ED; Bower D; Brigo A; Cammerer Z; Cronin MTD; Crooks I; Cross KP; Custer L; Dobo K; Doktorova T; Faulkner D; Ford KA; Fortin MC; Frericks M; Gad-McDonald SE; Gellatly N; Gerets H; Gervais V; Glowienke S; Van Gompel J; Harvey JS; Hillegass J; Honma M; Hsieh JH; Hsu CW; Barton-Maclaren TS; Johnson C; Jolly R; Jones D; Kemper R; Kenyon MO; Kruhlak NL; Kulkarni SA; Kümmerer K; Leavitt P; Masten S; Miller S; Moudgal C; Muster W; Paulino A; Lo Piparo E; Powley M; Quigley DP; Reddy MV; Richarz AN; Schilter B; Snyder RD; Stavitskaya L; Stidl R; Szabo DT; Teasdale A; Tice RR; Trejo-Martin A; Vuorinen A; Wall BA; Watts P; White AT; Wichard J; Witt KL; Woolley A; Woolley D; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2019 Oct; 107():104403. PubMed ID: 31195068
[TBL] [Abstract][Full Text] [Related]
32. In silico assessment of genotoxicity. Combinations of sensitive structural alerts minimize false negative predictions for all genotoxicity endpoints and can single out chemicals for which experimentation can be avoided.
Benigni R
Regul Toxicol Pharmacol; 2021 Nov; 126():105042. PubMed ID: 34506881
[TBL] [Abstract][Full Text] [Related]
33. Predicting the mutagenic potential of chemicals in tobacco products using
Goel R; Valerio LG
Toxicol Mech Methods; 2020 Nov; 30(9):672-678. PubMed ID: 32752976
[TBL] [Abstract][Full Text] [Related]
34. In silico prediction of genotoxicity.
Wichard JD
Food Chem Toxicol; 2017 Aug; 106(Pt B):595-599. PubMed ID: 27979779
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of 11 in silico models for the prediction of small molecule mutagenicity: role of steric hindrance and electron-withdrawing groups.
Ford KA; Ryslik G; Chan BK; Lewin-Koh SC; Almeida D; Stokes M; Gomez SR
Toxicol Mech Methods; 2017 Jan; 27(1):24-35. PubMed ID: 27813437
[TBL] [Abstract][Full Text] [Related]
36. Mechanistic Reactivity Descriptors for the Prediction of Ames Mutagenicity of Primary Aromatic Amines.
Kuhnke L; Ter Laak A; Göller AH
J Chem Inf Model; 2019 Feb; 59(2):668-672. PubMed ID: 30694664
[TBL] [Abstract][Full Text] [Related]
37. A local QSAR model based on the stability of nitrenium ions to support the ICH M7 expert review on the mutagenicity of primary aromatic amines.
Furukawa A; Ono S; Yamada K; Torimoto N; Asayama M; Muto S
Genes Environ; 2022 Mar; 44(1):10. PubMed ID: 35313995
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames test.
Harding AP; Popelier PL; Harvey J; Giddings A; Foster G; Kranz M
Regul Toxicol Pharmacol; 2015 Mar; 71(2):244-50. PubMed ID: 25542092
[TBL] [Abstract][Full Text] [Related]
39. Improvement of quantitative structure-activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project.
Honma M; Kitazawa A; Cayley A; Williams RV; Barber C; Hanser T; Saiakhov R; Chakravarti S; Myatt GJ; Cross KP; Benfenati E; Raitano G; Mekenyan O; Petkov P; Bossa C; Benigni R; Battistelli CL; Giuliani A; Tcheremenskaia O; DeMeo C; Norinder U; Koga H; Jose C; Jeliazkova N; Kochev N; Paskaleva V; Yang C; Daga PR; Clark RD; Rathman J
Mutagenesis; 2019 Mar; 34(1):3-16. PubMed ID: 30357358
[TBL] [Abstract][Full Text] [Related]
40. Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.
Coppi A; Davies R; Wegesser T; Ishida K; Karmel J; Han J; Aiello F; Xie Y; Corbett MT; Parsons AT; Monticello TM; Minocherhomji S
Regul Toxicol Pharmacol; 2022 Jun; 131():105162. PubMed ID: 35331777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
